These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 38517465)

  • 1. Population pharmacokinetics of daptomycin in critically ill patients receiving extracorporeal membrane oxygenation.
    Zhang LC; Li QY; Zhang YQ; Shan TC; Li Y; Li YH; Han H; Qin WD; Guo HP; Zhao W; Tang BH; Chen XM
    J Antimicrob Chemother; 2024 Jul; 79(7):1697-1705. PubMed ID: 38814793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of fluconazole in critically ill patients receiving extracorporeal membrane oxygenation and continuous renal replacement therapy: an ASAP ECMO study.
    Novy E; Abdul-Aziz MH; Cheng V; Burrows F; Buscher H; Corley A; Diehl A; Gilder E; Levkovich BJ; McGuinness S; Ordonez J; Parke R; Parker S; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA
    Antimicrob Agents Chemother; 2024 Jan; 68(1):e0120123. PubMed ID: 38063399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world evaluation of imipenem/cilastatin/relebactam across US medical centres.
    Shields RK; Yücel E; Turzhitsky V; Merchant S; Min JS; Watanabe AH
    J Glob Antimicrob Resist; 2024 Jun; 37():190-194. PubMed ID: 38588973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.
    Wu Y; Lu Z; Liang P; Zhu H; Qi H; Zhang H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4791-4798. PubMed ID: 38153513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of imipenem after intravenous, intramuscular and subcutaneous administration to cats.
    Albarellos GA; Denamiel GA; Montoya L; Quaine PC; Lupi MP; Landoni MF
    J Feline Med Surg; 2013 Jun; 15(6):483-7. PubMed ID: 23253883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation.
    Watt KM; Gonzalez D; Benjamin DK; Brouwer KL; Wade KC; Capparelli E; Barrett J; Cohen-Wolkowiez M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3935-43. PubMed ID: 25896706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
    Pokorná P; Michaličková D; Tibboel D; Berner J
    Antibiotics (Basel); 2024 May; 13(5):. PubMed ID: 38786147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Blood Product Resuscitation on Cefazolin Pharmacokinetics in Trauma Patients.
    Fouad A; Berry A; Gates J; Kuti JL; Keating JJ
    Surg Infect (Larchmt); 2024 Jul; ():. PubMed ID: 38995850
    [No Abstract]   [Full Text] [Related]  

  • 9. Correction: Relationship of imipenem therapeutic drug monitoring to clinical outcomes in critically ill patients: a retrospective cohort study.
    Wu Y; Lu Z; Liang P; Zhu H; Qi H; Zhang H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5329. PubMed ID: 38334826
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating imipenem + cilastatin + relebactam for the treatment of complicated urinary tract infections.
    Kuiper SG; Leegwater E; Wilms EB; van Nieuwkoop C
    Expert Opin Pharmacother; 2020 Oct; 21(15):1805-1811. PubMed ID: 32820669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem-Cilastatin-Relebactam: A Novel β-Lactam-β-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.
    Smith JR; Rybak JM; Claeys KC
    Pharmacotherapy; 2020 Apr; 40(4):343-356. PubMed ID: 32060929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation.
    Fratoni AJ; Kois AK; Gluck JA; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2024 May; 79(5):1118-1125. PubMed ID: 38517465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance.
    Fratoni AJ; Mah JW; Nicolau DP; Kuti JL
    J Antimicrob Chemother; 2022 Oct; 77(11):2992-2999. PubMed ID: 35906810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
    Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
    Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Children with Confirmed or Suspected Gram-Negative Bacterial Infections: A Phase 1b, Open-Label, Single-Dose Clinical Trial.
    Bradley JS; Makieieva N; Tøndel C; Roilides E; Kelly MS; Patel M; Vaddady P; Maniar A; Zhang Y; Paschke A; Chen LF
    J Clin Pharmacol; 2023 Dec; 63(12):1387-1397. PubMed ID: 37562063
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.